# Axsome Therapeutics, Inc. – FDA Inspection, Feb 6, 2026

Source: https://www.keypedia.com/records/fda_inspections/axsome-therapeutics-inc/d755cc61-e3b0-4906-a414-dc235848df39
Source feed: FDA_Inspections

> FDA inspection 1301534 of Axsome Therapeutics, Inc., February 06, 2026. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1301534
- Company Name: Axsome Therapeutics, Inc.
- Inspection Date: 2026-02-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New York District Office
- Citation Count: 2

## Related Documents

- FDA Inspection 1146168 - 2021-07-01

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/kerun-hardeo/d6c75a34-ab9b-4541-883d-102c6ec8c131)
- [FDA Associated Person](https://www.keypedia.com/people/omadevi-somai/8a6212bf-2dfa-44ea-bd2f-f2aeb78aa1bd)
- [Issuing Officer](https://www.keypedia.com/people/roberto-a-dookhan/01c2225f-a885-4421-9967-da323ce55cd8)

Company: https://www.keypedia.com/companies/axsome-therapeutics-inc/0bc3d1e2-dfe0-47ba-b144-4248f1fdfdf0

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d
